Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 114

1.

Medical resource use, costs, and quality of life in patients with acute decompensated heart failure: findings from ASCEND-HF.

Reed SD, Kaul P, Li Y, Eapen ZJ, Davidson-Ray L, Schulman KA, Massie BM, Armstrong PW, Starling RC, O'Connor CM, Hernandez AF, Califf RM.

J Card Fail. 2013 Sep;19(9):611-20. doi: 10.1016/j.cardfail.2013.07.003.

PMID:
24054337
2.

Assessment of dyspnea in acute decompensated heart failure: insights from ASCEND-HF (Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure) on the contributions of peak expiratory flow.

Ezekowitz JA, Hernandez AF, O'Connor CM, Starling RC, Proulx G, Weiss MH, Bakal JA, Califf RM, McMurray JJ, Armstrong PW.

J Am Coll Cardiol. 2012 Apr 17;59(16):1441-8. doi: 10.1016/j.jacc.2011.11.061.

3.

Nesiritide, renal function, and associated outcomes during hospitalization for acute decompensated heart failure: results from the Acute Study of Clinical Effectiveness of Nesiritide and Decompensated Heart Failure (ASCEND-HF).

van Deursen VM, Hernandez AF, Stebbins A, Hasselblad V, Ezekowitz JA, Califf RM, Gottlieb SS, O'Connor CM, Starling RC, Tang WH, McMurray JJ, Dickstein K, Voors AA.

Circulation. 2014 Sep 16;130(12):958-65. doi: 10.1161/CIRCULATIONAHA.113.003046. Epub 2014 Jul 29.

4.

Rationale and design of the Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure Trial (ASCEND-HF).

Hernandez AF, O'Connor CM, Starling RC, Reist CJ, Armstrong PW, Dickstein K, Lorenz TJ, Gibler WB, Hasselblad V, Komajda M, Massie B, McMurray JJ, Nieminen M, Rouleau JL, Swedberg K, Califf RM.

Am Heart J. 2009 Feb;157(2):271-7. doi: 10.1016/j.ahj.2008.07.031. Epub 2008 Dec 19.

PMID:
19185633
5.

Outcomes associated with vasoactive therapy in patients with acute decompensated heart failure.

Arnold LM, Crouch MA, Carroll NV, Oinonen MJ.

Pharmacotherapy. 2006 Aug;26(8):1078-85.

6.

Effect of nesiritide in patients with acute decompensated heart failure.

O'Connor CM, Starling RC, Hernandez AF, Armstrong PW, Dickstein K, Hasselblad V, Heizer GM, Komajda M, Massie BM, McMurray JJ, Nieminen MS, Reist CJ, Rouleau JL, Swedberg K, Adams KF Jr, Anker SD, Atar D, Battler A, Botero R, Bohidar NR, Butler J, Clausell N, Corbalán R, Costanzo MR, Dahlstrom U, Deckelbaum LI, Diaz R, Dunlap ME, Ezekowitz JA, Feldman D, Felker GM, Fonarow GC, Gennevois D, Gottlieb SS, Hill JA, Hollander JE, Howlett JG, Hudson MP, Kociol RD, Krum H, Laucevicius A, Levy WC, Méndez GF, Metra M, Mittal S, Oh BH, Pereira NL, Ponikowski P, Tang WH, Tanomsup S, Teerlink JR, Triposkiadis F, Troughton RW, Voors AA, Whellan DJ, Zannad F, Califf RM.

N Engl J Med. 2011 Jul 7;365(1):32-43. doi: 10.1056/NEJMoa1100171. Erratum in: N Engl J Med. 2011 Aug 25;365(8):773. Wilson, W H [corrected to Tang, W H W].

7.

Effect of nesiritide versus milrinone in the treatment of acute decompensated heart failure.

Lewis DA, Gurram NR, Abraham WT, Akers WS.

Am J Health Syst Pharm. 2003 Aug 15;60 Suppl 4:S16-20.

PMID:
12966902
8.

Differences in treatment, outcomes, and quality of life among patients with heart failure in Canada and the United States.

Kaul P, Reed SD, Hernandez AF, Howlett JG, Ezekowitz JA, Li Y, Zheng Y, Rouleau JL, Starling RC, O'Connor CM, Califf RM, Armstrong PW.

JACC Heart Fail. 2013 Dec;1(6):523-30. doi: 10.1016/j.jchf.2013.07.004. Epub 2013 Oct 23.

PMID:
24622005
9.
10.

Intravenous nesiritide in acute heart failure.

Knox MA, Dancy T, Mook W, Pschirer JJ.

Am J Ther. 2005 May-Jun;12(3):233-7.

PMID:
15891267
11.

Effects of nesiritide and predictors of urine output in acute decompensated heart failure: results from ASCEND-HF (acute study of clinical effectiveness of nesiritide and decompensated heart failure).

Gottlieb SS, Stebbins A, Voors AA, Hasselblad V, Ezekowitz JA, Califf RM, O'Connor CM, Starling RC, Hernandez AF.

J Am Coll Cardiol. 2013 Sep 24;62(13):1177-83. doi: 10.1016/j.jacc.2013.04.073. Epub 2013 Jun 7.

12.
13.

Acutely decompensated heart failure in a county emergency department: a double-blind randomized controlled comparison of nesiritide versus placebo treatment.

Miller AH, Nazeer S, Pepe P, Estes B, Gorman A, Yancy CW.

Ann Emerg Med. 2008 May;51(5):571-8. doi: 10.1016/j.annemergmed.2007.12.003. Epub 2008 Mar 4.

PMID:
18304693
14.

Impact of nesiritide on health care resource utilization and complications in patients with decompensated heart failure.

Lenz TL, Foral PA, Malesker MA, Hunter CB, Hilleman DE.

Pharmacotherapy. 2004 Sep;24(9):1137-46.

PMID:
15460174
15.

Comparative assessment of short-term adverse events in acute heart failure with cystatin C and other estimates of renal function: results from the ASCEND-HF trial.

Tang WH, Dupont M, Hernandez AF, Voors AA, Hsu AP, Felker GM, Butler J, Metra M, Anker SD, Troughton RW, Gottlieb SS, McMurray JJ, Armstrong PW, Massie BM, Califf RM, O'Connor CM, Starling RC.

JACC Heart Fail. 2015 Jan;3(1):40-9. doi: 10.1016/j.jchf.2014.06.014. Epub 2014 Nov 11.

PMID:
25453534
16.

Observation unit treatment of heart failure with nesiritide: results from the proaction trial.

Peacock WF 4th, Holland R, Gyarmathy R, Dunbar L, Klapholz M, Horton DP, de Lissovoy G, Emerman CL.

J Emerg Med. 2005 Oct;29(3):243-52.

PMID:
16183441
17.

Outcomes associated with nesiritide administration for acute decompensated heart failure in the emergency department observation unit: a single center experience.

Styron JF, Jois-Bilowich P, Tallman T, Emerman C, Starling RC, Frank Peacock W.

Congest Heart Fail. 2009 May-Jun;15(3):103-7. doi: 10.1111/j.1751-7133.2009.00065.x.

18.

Prognostic Value of Baseline and Changes in Circulating Soluble ST2 Levels and the Effects of Nesiritide in Acute Decompensated Heart Failure.

Tang WH, Wu Y, Grodin JL, Hsu AP, Hernandez AF, Butler J, Metra M, Voors AA, Felker GM, Troughton RW, Mills RM, McMurray JJ, Armstrong PW, O'Connor CM, Starling RC.

JACC Heart Fail. 2016 Jan;4(1):68-77. doi: 10.1016/j.jchf.2015.07.015. Epub 2015 Dec 2.

PMID:
26656144
19.

The ASCEND-HF trial: an acute study of clinical effectiveness of nesiritide and decompensated heart failure.

Dandamudi S, Chen HH.

Expert Rev Cardiovasc Ther. 2012 May;10(5):557-63. doi: 10.1586/erc.12.31.

PMID:
22651831
20.

Intravenous nesiritide, a natriuretic peptide, in the treatment of decompensated congestive heart failure. Nesiritide Study Group.

Colucci WS, Elkayam U, Horton DP, Abraham WT, Bourge RC, Johnson AD, Wagoner LE, Givertz MM, Liang CS, Neibaur M, Haught WH, LeJemtel TH.

N Engl J Med. 2000 Jul 27;343(4):246-53. Erratum in: N Engl J Med 2000 Sep 21;343(12):896. N Engl J Med 2000 Nov 16;343(20):1504.

Supplemental Content

Support Center